Unknown

Dataset Information

Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study.


ABSTRACT:

Objective

To determine the effect of low-dose propranolol on maximal exercise capacity in patients with postural tachycardia syndrome (POTS).

Methods

We compared the effect of placebo vs a single low dose of propranolol (20 mg) on peak oxygen consumption (VO2max), an established measure of exercise capacity, in 11 patients with POTS and 7 healthy subjects in a randomized, double-blind study. Subjects exercised on a semirecumbent bicycle, with increasing intervals of resistance to maximal effort.

Results

Maximal exercise capacity was similar between groups following placebo. Low-dose propranolol improved VO2max in patients with POTS (24.5 ± 0.7 placebo vs 27.6 ± 1.0 mL/min/kg propranolol; p = 0.024), but not healthy subjects. The increase in VO2max in POTS was associat

SUBMITTER: Arnold AC 

PROVIDER: S-EPMC3716342 | biostudies-literature | 2013 May

REPOSITORIES: biostudies-literature